Cargando…
Development of an integrated CRISPRi targeting ΔNp63 for treatment of squamous cell carcinoma
TP63 encodes TAp63, which is functionally similar to the tumor suppressor TP53, and ΔNp63, which lacks the transcription-activating domain of TAp63 and appears potently oncogenic in squamous cell carcinomas (SCCs). In this study, we developed an integrated CRISPR interference (CRISPRi) system to sel...
Autores principales: | Yoshida, Masakazu, Yokota, Etsuko, Sakuma, Tetsushi, Yamatsuji, Tomoki, Takigawa, Nagio, Ushijima, Toshikazu, Yamamoto, Takashi, Fukazawa, Takuya, Naomoto, Yoshio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044376/ https://www.ncbi.nlm.nih.gov/pubmed/30018747 http://dx.doi.org/10.18632/oncotarget.25678 |
Ejemplares similares
-
Clinical application of a lung cancer organoid (tumoroid) culture system
por: Yokota, Etsuko, et al.
Publicado: (2021) -
Targeted silencing of SOX2 by an artificial transcription factor showed antitumor effect in lung and esophageal squamous cell carcinoma
por: Yokota, Etsuko, et al.
Publicado: (2017) -
SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma
por: Fukazawa, Takuya, et al.
Publicado: (2016) -
A case report of left lower lobe segmentectomy for pulmonary metastasis from retroperitoneal liposarcoma
por: Yoshida, Kazuhiro, et al.
Publicado: (2019) -
Neuroendocrine tumor secondary to pulmonary hypoplasia: A case report
por: Yukawa, Takuro, et al.
Publicado: (2022)